Anti-Obesity Prescription Drugs Market: Segment Snapshot and Table of Content (2

Posted by vakhas on December 11th, 2017

Anti-Obesity Prescription Drugs Market : Segmental Highlights and Table of Content ( 2017-2026)

Anti-Obesity Prescription Drugs Market: Adult Age Group to Generate Significant Revenues

Increasing prevalence of obesity has led to an upsurge in demand for anti-obesity prescription drugs globally. In addition, increasing level of chronic stress is also expected to impact the global market growth of anti-obesity prescription drugs positively. Transparency Market Research states that the global anti-obesity prescription drugs market is projected to reflect a CAGR of 4.8% over the forecast period, 2017-2026.

Read Report overview @ https://www.transparencymarketresearch.com/antiobesity-prescription-drugs-market.html

As patients of high blood and sugar levels are more prone to the risk of obesity, doctors are increasingly prescribing liraglutide medicines. Based on the drug class, the liraglutide segment is projected to generate significant revenues, representing more than US$ 100 Mn by 2026-end. In contrary to this, the bupropion and naltrexone drug class segment is projected to reflect a significant CAGR through 2022. In terms of revenue, the adult age group segment is projected to account for more than US$ 100 Mn by 2017-end. This segment is projected to witness a robust CAGR in the global market of anti-obesity prescription drugs during the forecast period. By 2026-end, the hospital pharmacies distribution channel segment will continue to witness the fastest growth, accounting for more than US$ 100 Mn.

Request A Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=34835

Summary of Table of Content :

1. Global Anti-Obesity Prescription Drugs Market - Executive Summary

2. Global Anti-Obesity Prescription Drugs Market Overview

3. Global Anti-Obesity Prescription Drugs Market Analysis and Forecast 2012-2026

3.1. Global Anti-Obesity Prescription Drugs Market Size and Forecast By Drug Class, 2012-202

3.2. Global Anti-Obesity Prescription Drugs Market Size and Forecast By Age Group, 2012-2026

4. North America Anti-Obesity Prescription Drugs Market Size and Forecast, 2012-2026

5. Latin America Anti-Obesity Prescription Drugs Market Size and Forecast, 2012-2026

6. Europe Anti-Obesity Prescription Drugs Market Size and Forecast, 2012-2026

7. Japan Anti-Obesity Prescription Drugs Market Size and Forecast, 2012-2026

8. APEJ Anti-Obesity Prescription Drugs Market Size and Forecast, 2012-2026

ncreasing prevalence of obesity has led to an upsurge in demand for anti-obesity prescription drugs globally. In addition, increasing level of chronic stress is also expected to impact the global market growth of anti-obesity prescription drugs positively. Transparency Market Research states that the global anti-obesity prescription drugs market is projected to reflect a CAGR of 4.8% over the forecast period, 2017-2026.

9. MEA Anti-Obesity Prescription Drugs Market Size and Forecast, 2012-2026

10. Global Anti-Obesity Prescription Drugs Market Company Share, Competition Landscape and

11. Research Methodology

12. Secondary and Primary Sources

13. Assumptions and Acronyms

14. Disclaimer